BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interfero…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-07-13
News release - English.pdf
News 2026-07-06
BetterLife Engages Nucro-Technics to Complete the last GLP Toxicology Study of BETR-001 Required by the FDA for IND and Phase 1
News release - English.pdf
Transactions 2026-06-26 Financing
Report of exempt distribution (45-106F1).pdf
Results 2026-06-26
Interim MD&A - English.pdf
Results 2026-06-26
Interim financial statements/report – English.pdf
Transactions 2026-06-25 Financing
BetterLife Pharma Inc. Reports on Convertible Debenture Financing, Warrant Extension, and Stock Option Grants
Material change report - English.pdf
News 2026-06-25
BetterLife Engages Syner-G to Oversee GMP Manufacturing of BETR-001 for IND and Phase 1
News release - English.pdf
Ownership 2026-06-25
Doroudian, Ahmad bought +$6k
Insider trading – 2026-06-25
1 insider · +$6k net
Transactions 2026-06-22 Financing
BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing
News release - English.pdf
Ownership 2026-06-22
Drysdale, Douglas Lee · 16 - Acquisition or disposition under a prospectus exemption
Insider trading – 2026-06-22
1 insider · $0 net
Transactions 2026-06-17 Financing
BetterLife Pharma Announces Extension of Warrants
News release - English.pdf
Transactions 2026-06-15 Financing
BetterLife Pharma Announces Intent to Complete CAD $2 Million in Convertible Debenture to Complete BETR-001 IND Filing
News release - English.pdf
Ownership 2026-06-05
Sangha, Steven bought +$3k
Insider trading – 2026-06-05
1 insider · +$3k net
Ownership 2026-06-04
Sangha, Steven bought +$14k
Insider trading – 2026-06-04
1 insider · +$14k net
Results 2026-06-02
Annual information form - English.pdf
Ownership 2026-06-01
Sangha, Steven bought +$7k
Insider trading – 2026-06-01
1 insider · +$7k net
Results 2026-05-29
Annual MD&A - English.pdf
Results 2026-05-29
Audited annual financial statements – English.pdf
Ownership 2026-05-29
Sangha, Steven bought +$8k
Insider trading – 2026-05-29
1 insider · +$8k net
Ownership 2026-05-28
Sangha, Steven bought +$8k
Insider trading – 2026-05-28
1 insider · +$8k net
Ownership 2026-05-27
Sangha, Steven bought +$20k
Insider trading – 2026-05-27
1 insider · +$20k net
Ownership 2026-05-26
Sangha, Steven bought +$900
Insider trading – 2026-05-26
1 insider · +$900 net
Ownership 2026-05-25
Sangha, Steven sold +$9k
Insider trading – 2026-05-25
1 insider · −$9k net
Ownership 2026-05-12
Pullen, R. Anthony sold +$3k
Insider trading – 2026-05-12
1 insider · −$3k net
Ownership 2026-05-11
Pullen, R. Anthony sold +$8k
Insider trading – 2026-05-11
1 insider · −$8k net
Ownership 2026-05-07
Sangha, Steven bought +$17k
Insider trading – 2026-05-07
1 insider · +$17k net
Ownership 2026-05-01
Doroudian, Ahmad · 16 - Acquisition or disposition under a prospectus exemption
Insider trading – 2026-05-01
1 insider · $0 net
Ownership 2026-04-27
2 insiders · +$11k net
Insider trading – 2026-04-27
2 insiders · +$11k net
Ownership 2026-04-24
Sangha, Steven bought +$8k
Insider trading – 2026-04-24
1 insider · +$8k net
Transactions 2026-04-20 Financing
Report of exempt distribution (45-106F1).pdf
Transactions 2026-04-17 Financing
BetterLife Announces Closing of Private Placement
News release - English.pdf
Transactions 2026-04-10 Financing
BetterLife Pharma Announces Issuance of Shares and Extension of Convertible Debentures
News release - English.pdf
Transactions 2026-04-08 Financing
BetterLife Announces Private Placement Offering of Units
News release - English.pdf
Transactions 2026-04-02 Financing
BetterLife Pharma Announces Debt Conversions
News release - English.pdf
Ownership 2026-04-02
Sangha, Steven bought +$2k
Insider trading – 2026-04-02
1 insider · +$2k net
News 2026-01-06
BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco
News release - English.pdf
Results 2025-12-18 Financials
Interim MD&A - English.pdf
Results 2025-12-18 Financials
Interim financial statements/report – English.pdf
News 2025-12-11
BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital
News release - English.pdf
News 2025-12-04
BetterLife Pharma Highlights Advantages of BETR-001 – a Potent Neuroplastogen
News release - English.pdf
News 2025-11-14
News release - English.pdf
News 2025-10-21
News release - English.pdf
Results 2025-09-26 Financials
Interim MD&A - English.pdf
Results 2025-09-26 Financials
Interim financial statements/report – English.pdf
News 2025-07-28
Material change report - English.pdf